Yes! Cord blood transplant is another form of hematopoietic progenitor cell (HPC) transplant utilized for immune reconstitution. Below is standard an guidance from the Foundation for the Accreditation of Cellular Therapy (FACT). More information is available on the FACT website. STANDARD: B2.3.4 There shall be 24-hour availability of CMV-appropriate and irradiated blood products needed for the care of transplant patients. GUIDANCE: Those blood components suitable for CMV-negative recipients must be defined in the Standard Operating Procedures (SOPs) by the Clinical Program. If leukocyte-reduction is used to meet this standard, there must be a validated method in place (in the Transfusion Service) to ensure that components are suitably leukocyte-reduced. There must be a procedure in place for procurement ofirradiated blood products as needed for patient care.
Yes! Cord blood transplant is another form of hematopoietic progenitor cell (HPC) transplant utilized for immune reconstitution. Below is standard an guidance from the Foundation for the Accreditation of Cellular Therapy (FACT). More information is available on the FACT website. STANDARD: B2.3.4 There shall be 24-hour availability of CMV-appropriate and irradiated blood products needed for the care of transplant patients. GUIDANCE: Those blood components suitable for CMV-negative recipients must be defined in the Standard Operating Procedures (SOPs) by the Clinical Program. If leukocyte-reduction is used to meet this standard, there must be a validated method in place (in the Transfusion Service) to ensure that components are suitably leukocyte-reduced. There must be a procedure in place for procurement ofirradiated blood products as needed for patient care.